DSGN
Price
$7.06
Change
-$0.55 (-7.23%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
434.06M
124 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$31.81
Change
-$0.14 (-0.44%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.8B
138 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs IDYA

Header iconDSGN vs IDYA Comparison
Open Charts DSGN vs IDYABanner chart's image
Design Therapeutics
Price$7.06
Change-$0.55 (-7.23%)
Volume$2.76K
Capitalization434.06M
IDEAYA Biosciences
Price$31.81
Change-$0.14 (-0.44%)
Volume$10.63K
Capitalization2.8B
DSGN vs IDYA Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. IDYA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and IDYA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (DSGN: $7.61 vs. IDYA: $31.95)
Brand notoriety: DSGN and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 681% vs. IDYA: 69%
Market capitalization -- DSGN: $402.16M vs. IDYA: $2.79B
DSGN [@Biotechnology] is valued at $402.16M. IDYA’s [@Biotechnology] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • IDYA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than IDYA.

Price Growth

DSGN (@Biotechnology) experienced а +16.18% price change this week, while IDYA (@Biotechnology) price change was +7.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.8B) has a higher market cap than DSGN($434M). IDYA (24.319) and DSGN (23.339) have similar YTD gains . DSGN has higher annual earnings (EBITDA): -74.31M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. DSGN (216M). DSGN has less debt than IDYA: DSGN (1.95M) vs IDYA (26.6M). IDYA has higher revenues than DSGN: IDYA (7M) vs DSGN (0).
DSGNIDYADSGN / IDYA
Capitalization434M2.8B15%
EBITDA-74.31M-380.2M20%
Gain YTD23.33924.31996%
P/E RatioN/AN/A-
Revenue07M-
Total Cash216M670M32%
Total Debt1.95M26.6M7%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNIDYA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWEAX17.620.03
+0.17%
PACE International Em Mkts Eq A
PWJAX34.880.03
+0.09%
PGIM Jennison International Opps A
GSPRX34.32N/A
N/A
Goldman Sachs Large Cap Equity R
CCMMX9.29-0.01
-0.11%
Conestoga Mid Cap Investors
IJEMX13.59-0.03
-0.22%
VY® JPMorgan Emerging Markets Equity I

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-1.93%
IDYA - DSGN
51%
Loosely correlated
-0.19%
DYN - DSGN
50%
Loosely correlated
-5.39%
RNA - DSGN
48%
Loosely correlated
+0.17%
TRDA - DSGN
47%
Loosely correlated
+4.03%
VRDN - DSGN
46%
Loosely correlated
+1.79%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.19%
NUVL - IDYA
59%
Loosely correlated
+0.91%
NRIX - IDYA
58%
Loosely correlated
-5.37%
IMNM - IDYA
57%
Loosely correlated
-0.51%
CGON - IDYA
57%
Loosely correlated
+1.47%
XENE - IDYA
57%
Loosely correlated
-0.60%
More